Strategic Pharma Partnerships PHAR already collaborates with major pharma players (BMS, Genentech, PhRMA), indicating strong potential for deeper HEOR and outcomes research partnerships with additional top-tier firms.

Payer HEOR Expansion PHAR's focus on health economics and cost-effectiveness analyses positions them to help payers and market access teams; ready opportunities to offer end-to-end HEOR, pharmacoeconomic modeling, and reimbursement strategy services to expand post-approval work.

RWE Analytics In NMOSD and claims-based algorithm work, PHAR demonstrates RWE and data science capabilities; target biotech and pharma clients needing observational studies, patient identification, and real-world evidence programs.

Marketing Partnership PHAR's tech stack and emphasis on innovative marketing suggest a market to provide advanced digital marketing, content strategy, and thought leadership programs to attract and win pharma clients.

Global Scale Potential PHAR's revenue and partner history imply readiness for scalable, global services such as managed research programs, staff augmentation, and cross-border pricing research through a broader international footprint.